Literature DB >> 18805115

Prognostic usefulness of dyspnea versus fatigue as reason for exercise test termination in patients with heart failure.

Paul Chase1, Ross Arena, Jonathan Myers, Joshua Abella, Mary Ann Peberdy, Marco Guazzi, Aarti Kenjale, Daniel Bensimhon.   

Abstract

Cardiopulmonary exercise testing (CPX) is an integral tool for assessing the clinical status and prognosis of patients with heart failure (HF). The present investigation examined differences in CPX variables and prognosis according to reason for test termination. One hundred eighty-three patients with HF (69% men, 31% women; mean age 53 +/- 13 years, left ventricular ejection fraction at rest 24.3 +/- 9.9%) underwent CPX in which the minute ventilation/carbon dioxide production slope, peak oxygen consumption, and peak respiratory exchange ratio were determined. Subjects were tracked for cardiac-related events for 2 years after CPX. Dyspnea and fatigue (general fatigue/leg fatigue) were the primary reasons for test termination in 79 and 104 patients, respectively. Peak oxygen consumption (15.4 +/- 5.7 vs 17.5 +/- 5.9 ml o(2) . kg(-1) . min(-1)) was significantly lower, whereas minute ventilation/carbon dioxide production slope (38.5 +/- 12.8 vs 33.9 +/- 9.8) was significantly higher in the dyspnea subgroup (p <0.05). There were 41 cardiac-related events during the 2-year tracking period. Patients with dyspnea were at significantly higher risk of adverse events (hazard ratio 2.1, 95% confidence interval 1.1 to 4.0, p = 0.02). In conclusion, these results indicate that patients with HF terminating an exercise test primarily because of dyspnea have an increased incidence of cardiac-related events and poorer CPX markers than those limited by fatigue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805115     DOI: 10.1016/j.amjcard.2008.05.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Mechanisms by which exercise training benefits patients with heart failure.

Authors:  Ettore Crimi; Louis J Ignarro; Francesco Cacciatore; Claudio Napoli
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

2.  Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure.

Authors:  Paul J Chase; Aarti Kenjale; Lawrence P Cahalin; Ross Arena; Paul G Davis; Jonathan Myers; Marco Guazzi; Daniel E Forman; Euan Ashley; Mary Ann Peberdy; Erin West; Christopher T Kelly; Daniel R Bensimhon
Journal:  JACC Heart Fail       Date:  2013-09-11       Impact factor: 12.035

3.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

4.  The association of clinical indication for exercise stress testing with all-cause mortality: the FIT Project.

Authors:  Joonseok Kim; Mouaz Al-Mallah; Stephen P Juraschek; Clinton Brawner; Steve J Keteyian; Khurram Nasir; Zeina A Dardari; Roger S Blumenthal; Michael J Blaha
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

5.  Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue.

Authors:  Marco Morosin; Stefania Farina; Carlo Vignati; Emanuele Spadafora; Susanna Sciomer; Elisabetta Salvioni; Gianfranco Sinagra; Piergiuseppe Agostoni
Journal:  ESC Heart Fail       Date:  2017-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.